Kevin Joseph Fitzgerald

Insider Reports History

Location
Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Joseph Fitzgerald:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. CSO & EVP, Head of Research Common Stock 20,569 $6,710,430 $326.24 05 Mar 2026 Direct
ALNYLAM PHARMACEUTICALS, INC. CSO & EVP, Head of Research Common Stock 537 $173,064 $322.28 04 Mar 2026 by Managed Account
Ovid Therapeutics Inc. Director Employee Stock Option (Right to Buy) 65,000 26 Feb 2026 Direct
Ovid Therapeutics Inc. Director Stock Option (right to buy) 45,000 20 Feb 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. CSO & EVP, Head of Research Stock Option (right to buy) 8,105 02 Mar 2026 Direct

Insider Reports Filed by Kevin Joseph Fitzgerald

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALNY ALNYLAM PHARMACEUTICALS, INC. 04 Mar 2026 12 -$417,685 4 CSO & EVP, Head of Research 06 Mar 2026, 16:11
ALNY ALNYLAM PHARMACEUTICALS, INC. 02 Mar 2026 16 -$1,051,773 4 CSO & EVP, Head of Research 04 Mar 2026, 19:30
OVID Ovid Therapeutics Inc. 26 Feb 2026 1 $0 4 Director 02 Mar 2026, 16:30
ALNY ALNYLAM PHARMACEUTICALS, INC. 23 Feb 2026 1 $0 4 CSO & EVP, Head of Research 25 Feb 2026, 16:17
ALNY ALNYLAM PHARMACEUTICALS, INC. 12 Feb 2026 3 -$1,284,980 4 CSO & EVP, Head of Research 17 Feb 2026, 19:26
ALNY ALNYLAM PHARMACEUTICALS, INC. 11 Jan 2026 28 -$1,395,992 4 CSO & EVP, Head of Research 14 Jan 2026, 16:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 17 Nov 2025 13 -$4,511,770 4 CSO & EVP, Head of Research 19 Nov 2025, 16:05
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Oct 2025 14 -$1,103,451 4 CSO & EVP, Head of Research 03 Oct 2025, 17:13
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Aug 2025 9 -$632,759 4 CSO & EVP, Head of Research 19 Aug 2025, 17:26
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Jul 2025 1 $0 4 CSO & EVP, Head of Research 02 Jul 2025, 16:26
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Mar 2025 16 -$669,304 4 CSO & EVP, Head of Research 05 Mar 2025, 16:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 28 Feb 2025 8 -$119,878 4 CSO & EVP, Head of Research 03 Mar 2025, 16:30
OVID Ovid Therapeutics Inc. 20 Feb 2025 1 $0 4 Director 18 Jun 2025, 16:45
ALNY ALNYLAM PHARMACEUTICALS, INC. 13 Feb 2025 18 -$531,448 4 CSO & EVP, Head of Research 18 Feb 2025, 16:47
OVID Ovid Therapeutics Inc. 12 Dec 2024 1 $0 4 Director 16 Dec 2024, 16:15
ALNY ALNYLAM PHARMACEUTICALS, INC. 25 Nov 2024 10 -$754,947 4 CSO & EVP, Head of Research 27 Nov 2024, 17:20
ALNY ALNYLAM PHARMACEUTICALS, INC. 12 Aug 2024 10 -$4,122,086 4 CSO & EVP, Head of Research 14 Aug 2024, 16:12
ALNY ALNYLAM PHARMACEUTICALS, INC. 24 Jun 2024 13 -$276,731 4 CSO & EVP, Head of Research 26 Jun 2024, 16:26
ALNY ALNYLAM PHARMACEUTICALS, INC. 20 Mar 2024 0 $0 3 CSO & EVP, Head of Research 28 Mar 2024, 16:17
OVID Ovid Therapeutics Inc. 22 Feb 2024 1 $0 4 Director 26 Feb 2024, 17:56
OVID Ovid Therapeutics Inc. 23 Feb 2023 1 $0 4 Director 27 Feb 2023, 15:51
OVID Ovid Therapeutics Inc. 03 Feb 2022 1 $0 4 Director 04 Feb 2022, 19:49
OVID Ovid Therapeutics Inc. 06 Oct 2021 1 $0 4 Director 07 Oct 2021, 16:44
OVID Ovid Therapeutics Inc. 06 Oct 2021 0 $0 3 Director 07 Oct 2021, 16:27